Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
F50.0 Anorexia nervosa F50.2 Bulimia nervosa F50.8 Other eating disorders F50.9 Eating disorder, unspecified Accurate coding of eating disorders facilitates targeted therapeutic interventions and supports insurance reimbursement processes
acute post-procedural pain if relevant Diabetes Management (Underlying Etiology) Insulin (long-acting + short-acting) long-term insulin use: Z79.4 GLP-1 agonists (semaglutide, liraglutide), SGLT-2 inhibitors document type of diabetes and complications Metformin type 2 diabetes indicator Chronic Post-Amputation Pharmacology Neuropathic pain agents: Gabapentin, pregabalin, duloxetine phantom limb pain treatment (document G54.6) Tricyclic antidepressants: Amitriptyline phantom pain adjunct Calcitonin: Short-term phantom pain treatment Antiplatelets: Aspirin, clopidogrel ongoing PAD management
Researchers are responsible for adhering to all local, state, and federal regulations governing the handling, storage, and use of research chemicals
Innovation Rapid innovation in the sector supports the development of novel therapies that could prove even more effective and have fewer side effects
Your healthcare team will work with you on wound healing, fitting a prosthetic device if appropriate, and physical rehabilitation to help you regain as much function and independence as possible
US$ 27.50
US$ 28.92
US$ 29.02
US$ 27.00
